(Q39665811)

13 September 2017

title

Cross-linked fibrin degradation products (D-dimer), plasma cytokines, and cognitive decline in community-dwelling elderly persons (English)

1 reference

13 September 2017

Cross‐Linked Fibrin Degradation Products (D‐Dimer), Plasma Cytokines, and Cognitive Decline in Community‐Dwelling Elderly Persons (English)

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.2003.51454.X

fibrin degradation product

14 March 2024

main subject

0 references

3

Carl F. Pieper

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14511156

14 March 2024

author name string

Harvey Jay Cohen

2

1 reference

13 September 2017

Craig J. Wilson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14511156

14 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

13 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1532-5415.2003.51454.x

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.2003.51454.X

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1532-5415.2003.51454.x/fullpdf

14 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.2003.51454.X

Journal of the American Geriatrics Society

14 March 2024

published in

1 reference

13 September 2017

volume

51

1 reference

13 September 2017

issue

10

1 reference

13 September 2017

page(s)

1374-1381

1 reference

Age, functional status, and racial differences in plasma D-dimer levels in community-dwelling elderly persons

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2003.51454.X

The association of plasma IL-6 levels with functional disability in community-dwelling elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2003.51454.X

Serum IL-6 level and the development of disability in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2003.51454.X

A Short Portable Mental Status Questionnaire for the Assessment of Organic Brain Deficit in Elderly Patients†

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2003.51454.X

Association of interleukin-6 and other biologic variables with depression in older people living in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2003.51454.X

Cerebrovascular disease and depression symptoms in the cardiovascular health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2003.51454.X

Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2003.51454.X

Variability of plasma IL-6 and crosslinked fibrin dimers over time in community dwelling elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2003.51454.X

A Guttman health scale for the aged

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2003.51454.X

A High Plasma Concentration of TNF- Is Associated With Dementia in Centenarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2003.51454.X

Cytokines and cognition--the case for a head-to-toe inflammatory paradigm

21 January 2018

5

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.2003.51454.X

Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress

14 March 2024

6

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.2003.51454.X

Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro

14 March 2024

9

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.2003.51454.X

Fibrin D-dimer in thrombogenic disorders

14 March 2024

11

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.2003.51454.X

Activated coagulation/fibrinolysis system and platelet function in acute thrombotic stroke patients with increased C-reactive protein levels

14 March 2024

12

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.2003.51454.X

Hemostatic markers in ischemic stroke of undetermined etiology

14 March 2024

13

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.2003.51454.X

Sensitivity and specificity of standardized screens of cognitive impairment and dementia among elderly black and white community residents.

14 March 2024

17

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.2003.51454.X

Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly

14 March 2024

20

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.2003.51454.X

Coagulation activation in patients with Binswanger disease

14 March 2024

26

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.2003.51454.X

Study of cardiovascular risk factors and hemostatic molecular markers in elderly persons

14 March 2024

29

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.2003.51454.X

Enhancement of interleukin-6 production by fibrinogen degradation product D in human peripheral monocytes and perfused murine liver

14 March 2024

32

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.2003.51454.X

Prostaglandin-independent stimulation of interleukin-6 production by fibrinogen degradation product D in perfused murine liver

14 March 2024

33

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.2003.51454.X

Inflammation and Alzheimer's disease

14 March 2024

34

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.2003.51454.X

Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia.

14 March 2024

35

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.2003.51454.X

Blood levels of histamine, IL-1 beta, and TNF-alpha in patients with mild to moderate Alzheimer disease.

14 March 2024

36

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.2003.51454.X

Serum levels of interleukin-6 are not elevated in patients with Alzheimer's disease.

14 March 2024

39

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.2003.51454.X

Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease.

14 March 2024

40

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.2003.51454.X

Association of early-onset Alzheimer's disease with an interleukin-1? gene polymorphism

14 March 2024

44

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.2003.51454.X

A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease.

14 March 2024

45

1 reference

https://api.crossref.org/works/10.1046/J.1532-5415.2003.51454.X

14 March 2024

Identifiers

1 reference

13 September 2017

1 reference